{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:09:49Z","timestamp":1789265389595,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.pain.2005.02.032","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T09:53:33Z","timestamp":1113904413000},"page":"254-263","source":"Crossref","is-referenced-by-count":450,"title":["Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens"],"prefix":"10.1097","volume":"115","author":[{"given":"Rainer","family":"Freynhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Strojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Griesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Balkenohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.","volume":"280","author":"Backonja","year":"1998","journal-title":"J Am Med Assoc"},{"key":"R5-6-20210126","first-page":"18","article-title":"Herpetic neuralgia. Use of combination therapy for pain relief in acute and chronic herpes zoster.","volume":"56","author":"Bajwa","year":"2001","journal-title":"Geriatrics"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1345\/aph.10093","article-title":"Topiramate titration and tolerability.","volume":"35","author":"Biton","year":"2001","journal-title":"Ann Pharmacother"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/pgmj.73.864.623","article-title":"The management of postherpetic neuralgia.","volume":"73","author":"Bowsher","year":"1997","journal-title":"Postgrad Med J"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(02)50078-7","article-title":"Potential mechanisms of neuropathic pain in diabetes.","volume":"50","author":"Calcutt","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200112000-00029","article-title":"Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats.","volume":"95","author":"Chen","year":"2001","journal-title":"Anesthesiology"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1997.00440320117011","article-title":"Risk factors for postherpetic neuralgia.","volume":"157","author":"Choo","year":"1997","journal-title":"Arch Intern Med"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/jpet.302.3.1013","article-title":"Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat.","volume":"302","author":"Diop","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10094","article-title":"Preferential action of gabapentin and pregabalin at PQ-type voltage-sensitive calcium channels: inhibition of K-evoked 3Hnorepinephrine release from rat neocortical slices.","volume":"45","author":"Dooley","year":"2002","journal-title":"Synapse"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"R16-6-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","article-title":"Pain and its persistence in herpes zoster.","volume":"67","author":"Dworkin","year":"1996","journal-title":"Pain"},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/j.1875-9114.1990.tb02582.x","article-title":"Antidepressants in the management of chronic pain syndromes.","volume":"10","author":"Egbunike","year":"1990","journal-title":"Pharmacotherapy"},{"key":"R19-6-20210126","first-page":"162","article-title":"Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats.","volume":"295","author":"Eutamene","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","article-title":"Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat.","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"key":"R23-6-20210126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","article-title":"Inhibition of neuronal Ca2 influx by gabapentin and pregabalin in the human neocortex.","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology"},{"key":"R24-6-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002508-200309000-00001","article-title":"What is a meaningful pain reduction in patients with complex regional pain syndrome type 1?","volume":"19","author":"Forouzanfar","year":"2003","journal-title":"Clin J Pain"},{"issue":"1","key":"R26-6-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures.","volume":"27","author":"Hurst","year":"2004","journal-title":"J Manipulative Physiol Ther"},{"key":"R28-6-20210126","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2165\/00003495-200059050-00007","article-title":"Treatment of postherpetic neuralgia: an update.","volume":"59","author":"Kanazi","year":"2000","journal-title":"Drugs"},{"key":"R29-6-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","article-title":"Postherpetic neuralgia-pathogenesis, treatment, and prevention.","volume":"335","author":"Kost","year":"1996","journal-title":"N Engl J Med"},{"key":"R31-6-20210126","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion 2- calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"key":"R32-6-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3959(01)00316-5","article-title":"Gabapentin inhibits the substance P-facilitated K-evoked release of 3Hglutamate from rat caudal trigeminal nucleus slices.","volume":"93","author":"Maneuf","year":"2001","journal-title":"Pain"},{"key":"R34-6-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A systematic review of antidepressants in neuropathic pain.","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"issue":"4","key":"R35-6-20210126","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/eujp.2001.0259","article-title":"Peripheral neuropathic paina multidimensional burden for patients.","volume":"5","author":"Meyer-Rosberg","year":"2001","journal-title":"Eur J Pain"},{"key":"R39-6-20210126","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"R41-6-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-2008-1041083","article-title":"Postherpetic neuralgia.","volume":"14","author":"Rowbotham","year":"1994","journal-title":"Semin Neurol"},{"key":"R42-6-20210126","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.","volume":"280","author":"Rowbotham","year":"1998","journal-title":"J Am Med Assoc"},{"key":"R44-6-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1592\/phco.19.1.88.30515","article-title":"Slowing the initial titration rate of tramadol improves tolerability.","volume":"19","author":"Ruoff","year":"1999","journal-title":"Pharmacotherapy"},{"key":"R45-6-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Versavel M, the 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial.","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"R46-6-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy.","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin J Pain"},{"key":"R47-6-20210126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2165\/00002018-199106020-00005","article-title":"Risk-benefit assessment of carbamazepine in children.","volume":"6","author":"Seetharam","year":"1991","journal-title":"Drug Saf"},{"key":"R48-6-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-004-0035-7","article-title":"Current pharmacologic approaches to treating neuropathic pain.","volume":"8","author":"Vu","year":"2004","journal-title":"Curr Pain Headache Rep"},{"key":"R49-6-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/eujp.2002.0329","article-title":"Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy.","volume":"6","author":"Wallin","year":"2002","journal-title":"Eur J Pain"},{"key":"R51-6-20210126","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms, and management.","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"R50-6-20210126","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/j.1875-9114.1994.tb04161.x","article-title":"Review of the symptomatic treatment of diabetic neuropathy.","volume":"14","author":"Wright","year":"1994","journal-title":"Pharmacotherapy"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200506000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:49:05Z","timestamp":1785851345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200506000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2005.02.032","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}